Terms: = Bone cancer AND FES, FPS, 2242, ENSG00000182511, P07332 AND Diagnosis
4 results:
1. Quarter-Century Transformation of Oncology: Positron Emission Tomography for Patients with Breast cancer.
Ulaner GA; Vaz SC; Groheux D
PET Clin; 2024 Apr; 19(2):147-162. PubMed ID: 38177052
[TBL] [Abstract] [Full Text] [Related]
2. Heterogeneity of bone metastases as an important prognostic factor in patients affected by oestrogen receptor-positive breast cancer. The role of combined [18F]Fluoroestradiol PET/CT and [18F]Fluorodeoxyglucose PET/CT.
Bottoni G; Piccardo A; Fiz F; Siri G; Matteucci F; Rocca A; Nanni O; Monti M; Brain E; Alberini JL; Dib B; Sacchetti GM; Saggia C; Rossi V; Harbeck N; Wuerstlein R; Degenhardt T; DeCensi A; Rollandi GA; Gennari A
Eur J Radiol; 2021 Aug; 141():109821. PubMed ID: 34139575
[TBL] [Abstract] [Full Text] [Related]
3. Technical and nidus-specific factors associated with adequacy of intraprocedural biopsy samples preceding radiofrequency ablation of osteoid osteoma.
Soliman MM; Aguado A; Sutton C; Hameed M; Hwang S; Healey JH; Maybody M
Clin Imaging; 2020 May; 61():27-32. PubMed ID: 31954348
[TBL] [Abstract] [Full Text] [Related]
4. A comparison study of image features between FFDM and film mammogram images.
Jing H; Yang Y; Wernick MN; Yarusso LM; Nishikawa RM
Med Phys; 2012 Jul; 39(7):4386-94. PubMed ID: 22830771
[TBL] [Abstract] [Full Text] [Related]
